Cargando…
A novel double-targeted nondrug delivery system for targeting cancer stem cells
Instead of killing cancer stem cells (CSCs), the conventional chemotherapy used for cancer treatment promotes the enrichment of CSCs, which are responsible for tumor growth, metastasis, and recurrence. However, most therapeutic agents are only able to kill a small proportion of CSCs by targeting one...
Autores principales: | Qiao, Shupei, Zhao, Yufang, Geng, Shuai, Li, Yong, Hou, Xiaolu, Liu, Yi, Lin, Feng-Huei, Yao, Lifen, Tian, Weiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154727/ https://www.ncbi.nlm.nih.gov/pubmed/27994463 http://dx.doi.org/10.2147/IJN.S116230 |
Ejemplares similares
-
Diabetes Prevention, Early Intervention, and Nondrug Therapy
por: Zhao, Ruozhi, et al.
Publicado: (2017) -
Importance of nondrug costs of intravenous antibiotic therapy
por: van Zanten, Arthur RH, et al.
Publicado: (2003) -
Nondrug costs of therapy in acute care – are they important?
por: Edbrooke, David L, et al.
Publicado: (2003) -
Sustained co-delivery of BIO and IGF-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts
por: Fang, Rui, et al.
Publicado: (2015) -
Drug-eluting versus nondrug peripheral vascular interventions
por: Enezate, Tariq, et al.
Publicado: (2022)